🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for End-Stage Liver Disease

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF NCT03920618NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Real World Study of End-stage Liver Disease in China NCT04037995n/a1 site📍 Shanghai Huashan Hospital · Tests: No intervation Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates NCT07414095n/a1 site📍 Izmir Izmir Bakircay University · Tests: Comprehensive Observational Assessment in Liver Transplant Candidates COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device NCT06079021NA1 site📍 Edegem University Hospital, Antwerp · Tests: CytoSorb The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients NCT05030571NA1 site📍 Bangkok Chulalongkorn University · Tests: DPMAS, standard treatment Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy NCT06831565NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: ROTEM Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors NCT03803423NA6 sites📍 San Diego📍 New Haven📍 Chicago Johns Hopkins University · Tests: The Donor App ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF NCT07329036NA1 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: The artificial liver support system (ALSS) - DPMAS/TPE Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure NCT07275554n/a1 site📍 Jinan Qilu Hospital of Shandong University Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes NCT04496479Phase 22 sites📍 Boston📍 Houston LyGenesis, Inc. · Tests: LYG-LIV0001 Restrictive Fluid Management In Liver Transplantation (REFIL) NCT07695363NA4 sites📍 Vancouver📍 London📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Low splanchnic blood volume restrictive fluid management strategy, Phlebotomy, Optimized cardiac output liberal fluid m… CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites📍 Klagenfurt📍 Vienna📍 Aachen CytoSorbents, Inc · Tests: CytoSorb Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients NCT07519057NA1 site📍 Warsaw Medical University of Warsaw · Tests: Preoperative Oral Carbohydrate Loading, Placebo Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation NCT07561138NA2 sites📍 Athens📍 Athens Kalliopi Anna Poulia · Tests: Diet with even protein distribution plus exercise program, Diet with skewed protein distribution plus exercise program,… F573 for Injection for the Treatment of Liver Injury/Failure NCT05689645Phase 210 sites📍 Beijing📍 Qingyuan📍 Shiyan Beijing Continent Pharmaceutical Co, Ltd. · Tests: F573 for injection, Sterilizing water for injection Risk Factors Affecting MSC Efficacy in ACLF Patients NCT07198854n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: Not applicable- observational study Functional Assessment in Liver Transplantation NCT03228290n/a12 sites📍 Little Rock📍 Loma Linda📍 San Francisco University of California, San Francisco Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis NCT07438288n/a3 sites📍 Singapore📍 Singapore📍 Singapore Singapore General Hospital · Tests: Observation A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device. NCT07347275NA1 site📍 London Yaqrit Ltd · Tests: Standard of Care (Investigator Choice), DIALIVE 2.0 liver dialysis Device plus available Standard of Care Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients NCT06916585Phase 21 site📍 Shenzhen Shenzhen Third People's Hospital · Tests: AS1501 for injection Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs NCT04613921n/a106 sites📍 Los Angeles📍 Aurora📍 Tampa European Foundation for Study of Chronic Liver Failure · Tests: Observational Protocol Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis NCT06562803NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: double plasma cytokine adsorption system with sequential low-dose plasma exchange, plasma exchange Adverse Outcomes and Mortality in Liver Transplant NCT05477277NA1 site📍 Phoenix Mayo Clinic · Tests: MAsS Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients NCT06837766n/a3 sites📍 Ancona📍 Bologna📍 Milan IRCCS Azienda Ospedaliero-Universitaria di Bologna HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease NCT05205954NA2 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: Hepatology Home Hospital A Study of SIPLIZUMAB in AILD and LT Patients NCT06455280Phase 11 site📍 New York Elizabeth C. Verna · Tests: Siplizumab SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury NCT06173947n/a1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: FibroScan® Expert 630 Fecal Microbiota Transplantation for Liver Failure NCT05170971NA1 site📍 Ningbo Ningbo Medical Center Lihuili Hospital · Tests: fecal microbiota transplantation Vienna Hypothermic Oxygenated Machine Perfusion Study NCT06418165n/a1 site📍 Vienna Medical University of Vienna Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation NCT06749405NA1 site📍 Toulouse University Hospital, Toulouse · Tests: Transfusion algorithm based on Quantra®, Conventional transfusion algorithm
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy